• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Guillain-Barr? Syndrome and Influenza Virus Infection [Chicago Journals - Clinical Infectious Diseases]

Giuseppe

Emeritus
Guillain-Barr? Syndrome and Influenza Virus Infection [Chicago Journals - Clinical Infectious Diseases]

Clinical Infectious Diseases 2009;48:000?000
? 2008 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2009/4801-00XX$15.00
DOI: 10.1086/594124

MAJOR ARTICLE

Guillain-Barr? Syndrome and Influenza Virus Infection

Val?rie Sivadon-Tardy,1,2 David Orlikowski,2,3 Rapha?l Porcher,5,6 Tarek Sharshar,2,3 Marie-Christine Durand,2,4 Vincent Enouf,7,8 Flore Rozenberg,9,10 Christiane Caudie,11 Djillali Annane,2,3 Sylvie van der Werf,7,8P ierre Lebon,9,10 Jean-Claude Rapha?l,2,3 Jean-Louis Gaillard,1,2 and Elyanne Gault 1,2,7,8
1 Laboratoire de Microbiologie, H?pital Ambroise Par?, Assistance Publique?H?pitaux de Paris (AP-HP), Boulogne-Billancourt,
2 Universit? de Versailles?St. Quentin, Facult? de M?decine Paris-Ile-de-France-Ouest,
3 Service de R?animation, and
4 Physiologie et Explorations Fonctionnelles, H?pital Raymond Poincar? (AP-HP), Garches,
5 D?partement de Biostatistique et Informatique M?dicale, H?pital St.-Louis (AP-HP),
6 Universit? Paris Inserm U717,
7 Unit? de G?n?tique Mol?culaire des Virus Respiratoires, URA CNRS 3015, EA302 Universit? Paris 7,
8 Centre National de R?f?rence du Virus Influenza (R?gion Nord), Institut Pasteur,
9 Laboratoire de Virologie, H?pital Cochin?St. Vincent-de-Paul (AP-HP), and
10 Universit? Paris Descartes, Facult? de M?decine, Paris, and
11 F?d?ration de Biologie, Service d'Immunologie, H?pital Neurologique, Lyon, France


Background.
In Western countries, the cause of 60% of all Guillain-Barr? syndrome (GBS) cases remains unidentified. The number of cases of unidentified cause peaks in winter, and these cases are commonly preceded by respiratory tract infection or influenza-like illness. We investigated the triggering role of influenza virus infection.

Methods.
Of 405 patients with GBS who were admitted to a French reference center during 1996?2004, 234 had cases caused by an unidentified agent. We used time-series methods to study the correlation between the monthly incidence of such cases and influenza-like illnesses reported by the Sentinelles surveillance network. We analyzed anti-influenza antibodies using complement fixation testing and hemagglutination-inhibition assays. We studied etiological subgroups using Wilcoxon and Fisher's exact tests.

Results.
We found a positive association between the monthly incidence of GBS caused by an unidentified agent and reported influenza-like illnesses. Of 73 patients whose cases occurred during periods in which there was a possible link to influenza, 10 (13.7%) had serological evidence of recent influenza A, and 4 (5.5%) had serological evidence of influenza B. Eight of 10 influenza A?related cases occurred during ?major? influenza seasons, and antibodies specific to the current epidemic strain were found in 9 cases. Most patients with influenza A?related cases were aged <65 years, and none had antiganglioside antibodies. Influenza-related cases differed both from Campylobacter jejuni?related cases, with regard to the lack of need for mechanical ventilation ( ), and from the cases caused by an unidentified agent, with regard to the presence of preceding influenza-like illness or respiratory tract infection ( ) and longer time from the infectious event to GBS onset ( ).

Conclusions.
Influenza viruses are infrequent triggering agents of GBS but may play a significant role during major influenza outbreaks. Influenza-related GBS displays specific features and is not associated with antiganglioside antibody response, which suggests the presence of underlying immune mechanisms.

Received 3 June 2008; accepted 24 August 2008; electronically published 24 November 2008.
Reprints or correspondence: Dr. Elyanne Gault, Laboratoire de Microbiologie, H?pital Ambroise Par?, 9, ave. Charles de Gaulle, 92100 Boulogne-Billancourt, France (elyanne.gault@apr.aphp.fr)
-
<cite cite="http://www.journals.uchicago.edu/doi/abs/10.1086/594124">Chicago Journals - Clinical Infectious Diseases</cite>
 
Back
Top